The federal Food and Drug Administration (FDA) is tasked with the tremendous responsibility of keeping American consumers safe from dangerous drugs and medical devices. Accordingly, the agency has not only implemented strict pre-market testing and screening measures for new products, but it is required to monitor the products after their... Read more »

The drug Invokana belongs to a class of Type II diabetes medications known as sodium-glucose cotransporter-2 (SGLT2) inhibitors, and is referred to generically as canagliflozin. This class of drugs, which also includes well-known brands like Farxiga, Xigdua XR, Jardiance and Glyxambi, was once highly-touted as an innovative alternative for Type II... Read more »

On December 2, 2015, six additional claimants added their causes of action to the pending multidistrict litigation (MDL) involving the blood-thinning drug Xarelto. Xarelto, which is also known rivaroxaban, is a relatively new blood thinning drug touted to offer patients an increased level of convenience as they treat their underlying... Read more »

For many women, the hormonal fluctuations associated with pregnancy bring about unrelenting symptoms including nausea, vomiting and lightheadedness. In the most extreme cases, these women experience a condition known as hyperemesis gravidarum – which can cause dehydration and electrolyte imbalance. For years, doctors and healthcare professionals have prescribed a drug... Read more »

Known as a sodium-glucose cotransporter-2, the blockbuster diabetes drug Invokana has been flying off the shelves, launching it to the top of the class of drugs also including Farxiga, Jardiance, Xigduo XR and Glyxambi. The drug presents a new and innovative way to treat the presence of glucose in the... Read more »

On September 30, 2015, a husband and wife filed their complaint in the ongoing Testosterone Replacement Therapy Products multidistrict Litigation (MDL) against drug makers including AbbVie, Eli Lilly, Pfizer, and several others. These cases, which have been consolidated before Judge Matthew F. Kennelly of the U.S. District Court for the... Read more »

Times are changing within the realm of published medical studies. More and more, experts are questioning assertions made decades ago, choosing instead to examine data in a new light. As a result, retractions are at an all-time high, published works are proving to be inaccurate, the allegations of fraud are... Read more »

Adding to a growing body of research linking Risperdal and gynecomastia in young boys and men, a recent study published in the Journal of Child and Adolescent Psychopharmacology has revealed a correlation between the two following an intense look at over 15,000 cases. The study, which was published online ahead... Read more »

Morning sickness is a common, but severely debilitating, symptom of pregnancy that for some women lasts the entire gestational period. For a select unlucky few, the condition becomes so severe that constant vomiting prevents the intake of nutrition – placing the developing fetus in jeopardy. For these women, who suffer... Read more »

Manufactured by GlaxoSmithKline (GSK), the drug Zofran was first approved for use by the Food and Drug Administration (FDA) as ondansetron – an anti-nausea remedy in a class of medications known as a serotonin 5-HT3 receptor antagonists. The drug was first introduced to the market after FDA approval in January,... Read more »